Skip to main content

MORGAN STANLEY

Position in TRVI — Trevi Therapeutics, Inc.

CIK 895421 NEW YORK, NY

Position in TRVI

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$14,928,669
+$6,204,801 QoQ
Shares Held
800,465
+9.5% QoQ
Ownership
0.562%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#47
of 216 holders
Holding Since
Mar 2021
18 quarters on record
Voting authority Sole 86% Shared 0% None 14%

Common Shares in TRVI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,717,848,806 across 523 Biotechnology names. TRVI ranks #118 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TRVI

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $14,928,669 800,465
2026-03-31 $8,723,868 731,255
2025-12-31 $13,149,702 1,050,296
2025-09-30 $39,360,790 4,301,726
2025-06-30 $5,601,338 1,024,011
2025-03-31 $3,110,824 494,567
2024-12-31 $786,378 190,869
2024-09-30 $662,921 198,480
2024-06-30 $265,160 88,981
2024-03-31 $235,381 68,227
2023-12-31 $199,660 149,003
2023-09-30 $75,675 34,714
2023-06-30 $90,320 37,791
2023-03-31 $710 384
2022-12-31 $846 439
2022-09-30 $659,743 428,405
2022-03-31 $1,295 589
2021-03-31 $2,710 1,000